| Woodlawn Hospital | |
|
530 N Michigan St Argos IN 46501-1134 | |
| (574) 892-5131 | |
| (574) 224-1103 |
| Full Name | Woodlawn Hospital |
|---|---|
| Speciality | Clinic/Center |
| Location | 530 N Michigan St, Argos, Indiana |
| Authorized Official Name and Position | John Kraft (CFO) |
| Authorized Official Contact | 5742241118 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Woodlawn Hospital 1400 E 9th St Rochester IN 46975-8931 Ph: (574) 223-3141 | Woodlawn Hospital 530 N Michigan St Argos IN 46501-1134 Ph: (574) 892-5131 |
| NPI Number | 1962065847 |
|---|---|
| Provider Enumeration Date | 04/17/2019 |
| Last Update Date | 04/17/2019 |
| Medicare PECOS PAC ID | 4082506993 |
|---|---|
| Medicare Enrollment ID | O20190701001887 |
News Archive
UCLA researchers now have the first evidence that bacteria ingested in food can affect brain function in humans. In an early proof-of-concept study of healthy women, they found that women who regularly consumed beneficial bacteria known as probiotics through yogurt showed altered brain function, both while in a resting state and in response to an emotion-recognition task.
The Los Angeles Society of Pathologists, Inc. presented its Lifetime Achievement Award to Samuel W. French, MD, a principal investigator at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, on Jan. 15.
A program designed to boost cognition in older adults also increased their openness to new experiences, researchers report, demonstrating for the first time that a non-drug intervention in older adults can change a personality trait once thought to be fixed throughout the lifespan.
Alexion Pharmaceuticals, Inc. announced that it has purchased patents and assets from Germany-based Orphatec Pharmaceuticals GmbH related to an investigational therapy for patients with molybdenum cofactor deficiency (MoCD) Type A, a devastating ultra-rare genetic disorder characterized by severe brain damage and rapid death in newborns.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962065847 | NPI | - | NPPES |
| 100173660A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
UCLA researchers now have the first evidence that bacteria ingested in food can affect brain function in humans. In an early proof-of-concept study of healthy women, they found that women who regularly consumed beneficial bacteria known as probiotics through yogurt showed altered brain function, both while in a resting state and in response to an emotion-recognition task.
The Los Angeles Society of Pathologists, Inc. presented its Lifetime Achievement Award to Samuel W. French, MD, a principal investigator at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, on Jan. 15.
A program designed to boost cognition in older adults also increased their openness to new experiences, researchers report, demonstrating for the first time that a non-drug intervention in older adults can change a personality trait once thought to be fixed throughout the lifespan.
Alexion Pharmaceuticals, Inc. announced that it has purchased patents and assets from Germany-based Orphatec Pharmaceuticals GmbH related to an investigational therapy for patients with molybdenum cofactor deficiency (MoCD) Type A, a devastating ultra-rare genetic disorder characterized by severe brain damage and rapid death in newborns.
› Verified 7 days ago
Argos Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 530 N Michigan, Argos, IN 46501 Phone: 574-892-5131 Fax: 574-892-6349 |